Which feature best distinguishes lithium toxicity from lithium therapeutic effect in a 52-year-old patient with bipolar disorder on maintenance lithium therapy?

Explanation

## Distinguishing Lithium Toxicity from Therapeutic Effect ### Therapeutic vs. Toxic Manifestations **Key Point:** Lithium has a narrow therapeutic window (0.6–1.2 mEq/L); toxicity emerges at levels >1.5 mEq/L, with severity increasing sharply above 2.5 mEq/L. | Feature | Therapeutic Effect | Toxicity (Mild–Moderate) | Toxicity (Severe) | |---------|-------------------|--------------------------|-------------------| | **Tremor** | Fine, high-frequency | Fine to coarse | Coarse tremor | | **GI symptoms** | Nausea, diarrhea (early) | Persistent vomiting | Severe, intractable | | **CNS** | None | Drowsiness, lethargy | Confusion, ataxia, slurred speech | | **Renal** | Polyuria, polydipsia | Polyuria persists | Oliguria (severe) | | **Serum level** | 0.6–1.2 mEq/L | 1.5–2.5 mEq/L | >2.5 mEq/L | | **Cardiac** | None | None | Arrhythmias, ECG changes | **High-Yield:** The **coarse tremor + CNS signs (confusion, ataxia) + high serum level (>2.5 mEq/L)** triad is pathognomonic for lithium toxicity and distinguishes it from the benign fine tremor and polyuria of therapeutic dosing. **Clinical Pearl:** Fine tremor and polyuria are expected at therapeutic levels and do NOT warrant dose reduction unless intolerable. Coarse tremor with neurological signs mandates immediate cessation and supportive care (hydration, dialysis if severe). **Warning:** Do not confuse fine tremor (therapeutic) with coarse tremor (toxic). Fine tremor alone is NOT an indication to stop lithium. ### Mechanism of Toxicity Lithium toxicity arises from: 1. Accumulation in CNS and renal tissue (narrow clearance margin) 2. Displacement of Na⁺ in excitable tissues → hyperexcitability, then depression 3. Impaired renal concentrating ability → polyuria and dehydration → further accumulation [cite:KD Tripathi 8e Ch 12]